BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Neoplasm Metastasis

Below is an extended Neoplasm Metastasis research listing. Click here to return to the Neoplasm Metastasis main in depth entry.

Recent Publications on Neoplasm Metastasis:

Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines.
PURPOSE: To identify prognostic factors associated with survival beyond 4...
Direct Link
4th October, 2008
Surgery Branch, Center for Cancer Research, National Cancer Institute,
Combination of quantitative IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas.
PURPOSE: To create an easily applicable system based on a combination of...
Direct Link
4th October, 2008
Department of Pathology, University of Massachusetts Medical Center,
Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma.
PURPOSE: To measure changes in tumor blood flow following treatment with...
Direct Link
4th October, 2008
Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
PURPOSE: Tumor metastasis continues to be the major obstacle to cancer...
Direct Link
4th October, 2008
Cancer Biology Research Center, Tongji Hospital, Tongji Medical College,
Matuzumab short-term therapy in experimental pancreatic cancer: prolonged antitumor activity in combination with gemcitabine.
PURPOSE: The epidermal growth factor receptor ErbB-1 is commonly expressed...
Direct Link
4th October, 2008
Department of Surgery, Klinikum Grosshadern, Ludwig-Maximilian-University,
Treatment of metastatic ErbB2-positive breast cancer: options after progression on trastuzumab. 1st October, 2008
Duke Comprehensive Cancer Center, Durham, NC 27705, USA.
A microRNA DNA methylation signature for human cancer metastasis.
MicroRNAs (miRNAs) are small, noncoding RNAs that can contribute to cancer...
Direct Link
1st October, 2008
Cancer Epigenetics Laboratory, Spanish National Cancer Research Center,
Cell fusion theory: can it explain what triggers metastasis?
Three breast carcinoma cell lines --21PTCi, 21NTCi, and 21MT-1 --all...
Direct Link
30th September, 2008
Metastatic non-small cell lung cancer: costs associated with disease progression. 30th September, 2008
Strategic Healthcare Solutions, LLC, PO Box 543, Monkton, MD 21111, USA.
Distinct karyotypes in three breast cancer cell lines --21PTCi, 21NTCi, and 21MT-1 --derived from the same patient and representing different stages of tumor progression.
Three breast carcinoma cell lines --21PTCi, 21NTCi, and 21MT-1 --all...
Direct Link
27th September, 2008
Cytogenetics Laboratory, London Health Sciences Centre, University of
Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer.
Human cancers have been found to include transformed stem cells that may...
Direct Link
25th September, 2008
Predication of cancer patients' survival by pain interference items is not the same as evidence that pain intensity is a survival predictor.
Human cancers have been found to include transformed stem cells that may...
Direct Link
25th September, 2008
A stochastic model for cancer stem cell origin in metastatic colon cancer.
Human cancers have been found to include transformed stem cells that may...
Direct Link
19th September, 2008
McGowan Institute for Regenerative Medicine, Department of Pathology,
[Diagnosis of lung neoplasma by endobronchial ultrasound-guided transbronchial needle aspiration-diagnosis of metastasis and therapeutics] 16th September, 2008
Department of Thoracic Surgery, Chiba University, Chiba, Japan.
[Thorax/lung and mediastinum, pleura cancer] 16th September, 2008
Department of Thoracic Oncology, Kyushu Cancer Center, Fukuoka, Japan.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional